肺癌中表皮生长因子受体基因的临床和生物学特点。
Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung Cancers.
目的探讨表皮生长因子受体与细胞增殖、转化的关系。
Objective to explore the relationship between epidermal growth factor receptor (EGFR) and cell proliferation and transformation.
肺癌中表皮生长因子受体的突变及对靶向治疗的敏感性。
Epidermal growth factor receptor mutations and susceptibility to targeted therapy in lung cancer.
目的研究表皮生长因子受体在卵巢癌中的表达及其临床意义。
Objective To study the Expression and clinical significance of EGFR in ovarian cancer.
目的研究表皮生长因子受体在卵巢癌中的表达及其临床意义。
EGFR played an important role in the development of ovarian cancer.
非小细胞肺癌病人的表皮生长因子受体基因突变的临床病理意义。
Clinicopathologic Significance of the Mutations of the Epidermal Growth Factor Receptor Gene in Patients with Non-Small Cell Lung Cancer.
免疫细胞化学染色法检测表皮生长因子受体（EGFR）的表达；
The immunocytochemical stain and image analysis were applied to measure the expression of EGFR protein.
目的：探讨表皮生长因子受体基因表达与胶质瘤恶性程度的关系。
Objective: To investigate the expression of EGFR gene in human gliomas.
例如，艾比特思和名为表皮生长因子受体(EGFR)的细胞表面蛋白的结合。
Erbitux, for example, binds to a cell-surface protein called epidermal growth-factor receptor (EGFR).
首次报道从人胎盘绒毛组织提取表皮生长因子受体，并制备受体抗体。
Antibodies were prepared against epidermal growth factor receptor isolated from human placental villus tissue.
它的目标是一种蛋白质：驱动肿瘤生长的表皮生长因子受体(EGFR)。
It targets a protein - epidermal growth factor receptor (EGFR) - which drives tumour growth.
目的探讨表皮生长因子受体反义重组腺病毒联合放射线对乳腺癌细胞的作用。
Objective to investigate the effects of a recombinant antisense adenovirus for epidermal growth factor receptor combined with irradiation on breast cancer cells.
目的研究抑制素、表皮生长因子受体在人卵巢颗粒细胞瘤中的表达及临床意义。
Objective To investigate the expression of inhibin, epidermal growth factor receptor in human ovarian granulosa cell tumor and their clinical significance.
目的：了解表皮生长因子受体抑制剂AG1487对舌鳞癌细胞的抑制增殖作用。
Objective:To investigate the inhibitory effect of epidermal growth factor receptor inhibitor AG1487 on the proliferation of tongue cancer cells.
目的：研究表皮生长因子受体和增殖细胞核抗原在胃肿瘤中的表达及其临床意义。
Objective: To study the expression of EGFR and PCNA protein in human gastric neoplasm and its clinical significance.
2010年人表皮生长因子受体2检测：17号染色体着丝粒拷贝数是否具有影响？
Human Epidermal Growth Factor Receptor 2 Testing in 2010: Does Chromosome 17 Centromere Copy Number Make Any Difference?
中国的非小细胞肺癌病人中吉非替尼敏感的表皮生长因子受体酪氨酸激酶区域的突变。
Gefitinib-sensitive mutations of the epidermal growth factor receptor tyrosine kinase domain in chinese patients with non-small cell lung cancer.
结论：表皮生长因子受体抑制剂ag1487可对舌鳞癌细胞产生明显的增殖抑制作用。
Conclusion: Epidermal growth factor receptor inhibitor AG1487 may retard cell cycle, and then inhibit the proliferation of tumor cells.
目的：研究表皮生长因子受体(EGFR)在口腔鳞癌组织中的表达及其临床病理学意义。
Purpose to study the expression and clinicopathological significance of epidermal growth factor receptor (EGFR) in oral squamous cell carcinoma (OSCC).
表皮生长因子受体(EGFR)通路下游基因的激活突变可以引起结直肠癌患者抗egfr耐药。
Activating mutations in downstream genes of the epidermal growth factor receptor (EGFR) pathway may cause anti-EGFR resistance in patients with colorectal cancers.
共有210名患有人表皮生长因子受体2 (HER2)阳性的早期乳腺癌的女性患者参加了实验。
A total of 210 women with early breast cancer who tested positive for human epidermal growth factor receptor 2 (HER2) were enrolled.
目的研究表皮生长因子受体在妊娠滋养细胞疾病的表达，探讨EGFR对预测葡萄胎恶变的价值。
Results Stain for EGFR was detected in all cell types of trophoblasts in GTD and normal chorion villi.
许多种类的肿瘤可产生比普通细胞高得多的表皮生长因子受体，影响之一就是刺激了肿瘤细胞的扩散。
Many types of tumour produce far more EGFR than normal cells do, and one effect of that is to stimulate the proliferation of tumour cells.
表皮生长因子受体（EGFR）及其配体的过表达与疾病的迅速进展和对化疗的耐药有密切的联系。
The overexpression of the epidermal growth factor receptor and its ligands correlates with rapidly progressive disease and resistance to chemotherapy.
这种新药是用于治疗乳腺癌，这种携带了表皮生长因子受体2（Her-2）的特异生物标记的疾病。
The new drug is targeted to treat breast cancers that carry a special genetic marker, known as HER2.
目的探讨中国人非小细胞肺癌表皮生长因子受体(EGFR)第18、19、21外显子基因突变状态。
Objective to study the mutation patterns of epithelial growth factor receptor (EGFR) exon 18, 19 and 21 in Chinese non-small-cell lung cancers (NSCLC).
他在介绍时的血清肌酐为1.3毫克/升（估计肾小球滤过率[表皮生长因子受体]57毫升/分钟）。
His serum creatinine at the time of presentation was 1.3 mg/dL (estimated glomerular filtration rate [eG FR] 57 mL/min).
目的探讨含紫杉醇类辅助化疗方案对HER - 2(表皮生长因子受体2)阳性乳腺癌患者生存率的影响。
Objective To investigate the effects of survival rate in the use of adjuvant chemotherapy containing paclitaxel on patients with breast cancer of HER-2 positive.
目的探讨含紫杉醇类辅助化疗方案对HER - 2(表皮生长因子受体2)阳性乳腺癌患者生存率的影响。
Objective To investigate the effects of survival rate in the use of adjuvant chemotherapy containing paclitaxel on patients with breast cancer of HER-2 positive.
应用推荐